IGMIN: We're glad you're here. Please click 'create a new query' if you are a new visitor to our website and need further information from us.
If you are already a member of our network and need to keep track of any developments regarding a question you have already submitted, click 'take me to my Query.'
Welcome to IgMin Research – an Open Access journal uniting Biology, Medicine, and Engineering. We’re dedicated to advancing global knowledge and fostering collaboration across scientific fields.
At IgMin Research, we bridge the frontiers of Biology, Medicine, and Engineering to foster interdisciplinary innovation. Our expanded scope now embraces a wide spectrum of scientific disciplines, empowering global researchers to explore, contribute, and collaborate through open access.
Welcome to IgMin, a leading platform dedicated to enhancing knowledge dissemination and professional growth across multiple fields of science, technology, and the humanities. We believe in the power of open access, collaboration, and innovation. Our goal is to provide individuals and organizations with the tools they need to succeed in the global knowledge economy.
IgMin Publications Inc., Suite 102, West Hartford, CT - 06110, USA
Our purpose is to inspire collaborative dialogue among scientific fields and foster accelerated knowledge development.
Biography
Vaibhav Gupta is an emerging scholar based in India, currently affiliated with Jamia Hamdard University, New Delhi, where he is associated with the School of Pharmaceutical Education and Research (SPER). He is recognized for his contributions to nanotechnology and medicinal chemistry, as featured in IgMin Research, a multidisciplinary open-access journal covering biology, medicine, and engineering.
Gupta’s work has garnered attention through his co-authorship of the review article titled “Nanorobots in Medicine: Advancing Healthcare through Molecular Engineering: A Comprehensive Review”, published in November 2024. Alongside Mahima Antil, Gupta explored state‑of‑the‑art developments in nanorobotics including structural designs, energy systems, and propulsion techniques. The review emphasizes applications in targeted drug delivery, diagnostics, minimally invasive surgery, and infection control, underscoring the transformative potential of nanorobotics in precision medicine.
Beyond his published review, Gupta maintains a robust academic profile, engaging in interdisciplinary research that bridges pharmaceutical sciences and emerging nanotechnologies. His contributions underscore growing trends in nano-scaled therapeutic tools, demonstrating both theoretical insight and clinical relevance. At Jamia Hamdard, Gupta is actively involved in mentoring students and collaborating on research at the intersection of biomedical engineering and chemistry.
Overall, Vaibhav Gupta represents a dynamic force in India’s scientific landscape. His dedication to exploring and expanding nanorobotic systems reflects a broader commitment to revolutionizing healthcare delivery through molecular-scale innovation.
Research Interest
Vaibhav Gupta’s research interests lie at the intersection of nanotechnology, pharmaceutical sciences, and biomedical engineering. He is particularly focused on the development and application of nanorobotic systems for targeted drug delivery, diagnostics, and minimally invasive medical procedures. His work explores the structural design, energy sources, and propulsion mechanisms of nanorobots, aiming to improve precision and efficiency in therapeutic interventions. Gupta is also interested in molecular engineering approaches to enhance drug bioavailability and reduce systemic side effects. In addition, he studies smart drug delivery systems, bio-compatible materials, and micro/nano-scale devices that interact seamlessly with human tissues. His interdisciplinary approach bridges chemistry, biology, and engineering to address complex healthcare challenges. Through his research, Gupta aims to contribute to the evolution of personalized medicine, improving treatment outcomes by tailoring therapeutic tools to individual patient needs using nano-scale innovations. His work reflects a commitment to advancing futuristic technologies in real-world clinical settings.
Open Access Policy refers to a set of principles and guidelines aimed at providing unrestricted access to scholarly research and literature. It promotes the free availability and unrestricted use of research outputs, enabling researchers, students, and the general public to access, read, download, and distribute scholarly articles without financial or legal barriers. In this response, I will provide you with an overview of the history and latest resolutions related to Open Access Policy.
Nanotechnology, particularly nanorobotics, has emerged as a transformative force in modern medicine. Nanorobots, designed at the molecular scale, hold promise for a range of medical applications, including targeted drug delivery, early disease diagnostics, minimally invasive surgeries, and precise infection control. Their unique ability to interact with biological systems at the cellular level opens avenues for significant advancements in treatment protocols, potentially overcoming current limitations in traditional therapies. This review delve...s into the development, mechanisms, and diverse medical applications of nanorobots, highlighting their structural components, energy sources, and propulsion methods. Additionally, we explore specific case studies in cancer treatment, infection control, and surgical innovations, assessing both the advancements and challenges associated with nanorobotic technologies. The goal is to present a comprehensive overview that underscores the potential of nanorobots to revolutionize patient care and set the stage for future research in this burgeoning field.
0000-0002-2500-0029 
